Cargando…
Identification of potent maturation inhibitors against HIV-1 clade C
Antiretroviral therapy has led to a profound improvement in the clinical care of HIV-infected patients. However, drug tolerability and the evolution of drug resistance have limited treatment options for many patients. Maturation inhibitors are a new class of antiretroviral agents for treatment of HI...
Autores principales: | Timilsina, Uddhav, Ghimire, Dibya, Timalsina, Bivek, Nitz, Theodore J., Wild, Carl T., Freed, Eric O., Gaur, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893694/ https://www.ncbi.nlm.nih.gov/pubmed/27264714 http://dx.doi.org/10.1038/srep27403 |
Ejemplares similares
-
Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C
por: Ghimire, Dibya, et al.
Publicado: (2017) -
A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors
por: Ghimire, Dibya, et al.
Publicado: (2021) -
Anesthetic management of congenital epulis in a newborn: a case report
por: Dulal, Aliza, et al.
Publicado: (2023) -
SERINC5 Potently Restricts Retrovirus Infection In Vivo
por: Timilsina, Uddhav, et al.
Publicado: (2020) -
Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice
por: Stoddart, Cheryl A., et al.
Publicado: (2007)